ELTX logo

Elicio Therapeutics, Inc.

ELTX
Healthcare|Biotechnology|US
$1.51
+0.11 (+7.86%)
DCF Value
$0.23
Tangible Book / Share
$0.72
Cash / Share
$1.18

Ownership Breakdown

46.6%
Float
19.1M
Shares Outstanding
8.9M
Float Shares

Major Holders (7)

Combined: 119.6%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
GKCC, LLCPartnership48.00%9,752,139Jun 4, 202513D/G
Yekaterina ChudnovskyIndividual48.00%9,764,864Jun 4, 202513D/G
Moti Investments LLCOther6.10%1,408,892Jul 16, 202613D/G
Gakasa Holdings, LLCOther5.30%1,211,957Jul 8, 202613D/G
Fred KnollIndividual5.30%1,211,957Jul 8, 202613D/G
Knoll Capital Management, LLCOther5.30%1,211,957Jul 8, 202613D/G
Actyus Private Equity SGIIC, S.A.FI, IV1.60%268,564Oct 7, 202513D/G

Insider Trades (61)

Last 4 quarters: 1,299,413 acquired · 362 disposed
InsiderPositionDateTypeSharesPriceValueFiling
ADAMS JULIANdirectorAug 31, 2026AWARD21,750$2.70$58.7KForm 4
Ashe Carol GaildirectorAug 31, 2026AWARD21,750$2.70$58.7KForm 4
Chudnovsky Yekaterinadirector, 10 percent owner: Aug 31, 2026AWARD21,750$2.70$58.7KForm 4
Nissenson AllendirectorAug 31, 2026AWARD21,750$2.70$58.7KForm 4
RUFFOLO ROBERT RdirectorAug 31, 2026AWARD21,750$2.70$58.7KForm 4
WILSON KAREN JdirectorAug 31, 2026AWARD21,750$2.70$58.7KForm 4
Venkatesan JaydirectorAug 31, 2026AWARD21,750$2.70$58.7KForm 4
Haqq ChristopherSee RemarksJul 16, 2026AWARD64,643$3.20$206.9KForm 4
DeMuth PeterChief Scientific OfficerJul 16, 2026AWARD52,832$3.20$169.1KForm 4
Shah PreetamSee RemarksJul 16, 2026AWARD60,833$3.20$194.7KForm 4
Connelly Robertdirector, officer: CEO, President and DirectorJul 16, 2026AWARD186,944$3.20$598.2KForm 4
Connelly Robertdirector, officer: CEO, President and DirectorFeb 2, 2026AWARD147,200$8.10$1.2MForm 4
Connelly Robertdirector, officer: CEO, President and DirectorFeb 2, 2026AWARD73,600——Form 4
Shah PreetamSee RemarksFeb 2, 2026AWARD47,900$8.10$388.0KForm 4
Shah PreetamSee RemarksFeb 2, 2026AWARD24,000——Form 4
DeMuth PeterChief Scientific OfficerFeb 2, 2026AWARD41,600$8.10$337.0KForm 4
DeMuth PeterChief Scientific OfficerFeb 2, 2026AWARD20,800——Form 4
Haqq ChristopherSee RemarksFeb 2, 2026AWARD25,400——Form 4
Haqq ChristopherSee RemarksFeb 2, 2026AWARD50,900$8.10$412.3KForm 4
DeMuth PeterChief Scientific OfficerDec 9, 2025OPTION EX.362$4.41$1.6KForm 4
DeMuth PeterChief Scientific OfficerDec 9, 2025OPTION EX.362$4.41$1.6KForm 4
Chudnovsky Yekaterinadirector, 10 percent owner: Jun 3, 2025AWARD103,225$7.75$800.0KForm 4
Ashe Carol GaildirectorMay 19, 2025AWARD7,900$5.84$46.1KForm 4
Nissenson AllendirectorMay 19, 2025AWARD7,900$5.84$46.1KForm 4
Venkatesan JaydirectorMay 19, 2025AWARD7,900$5.84$46.1KForm 4
ADAMS JULIANdirectorMay 19, 2025AWARD7,900$5.84$46.1KForm 4
WILSON KAREN JdirectorMay 19, 2025AWARD7,900$5.84$46.1KForm 4
RUFFOLO ROBERT RdirectorMay 19, 2025AWARD7,900$5.84$46.1KForm 4
Chudnovsky Yekaterinadirector, 10 percent owner: May 19, 2025AWARD7,900$5.84$46.1KForm 4
Shah PreetamSee RemarksApr 15, 2025AWARD191,624$4.98$954.3KForm 4
Shah PreetamofficerMar 24, 2025OTHER0——Form 4
Chudnovsky Yekaterinadirector, 10 percent owner: Mar 5, 2025CONVERSION3,500,573$5.81$20.3MForm 4
Chudnovsky Yekaterinadirector, 10 percent owner: Mar 5, 2025CONVERSION3,442,341$5.81$20.0MForm 4
DeMuth PeterChief Scientific OfficerFeb 3, 2025AWARD44,400$8.92$396.0KForm 4
Haqq ChristopherSee RemarksFeb 3, 2025AWARD44,000$8.92$392.5KForm 4
Connelly Robertdirector, officer: CEO, President and DirectorFeb 3, 2025AWARD121,600$8.92$1.1MForm 4
DeMuth PeterChief Scientific OfficerDec 16, 2024OPTION EX.381$4.41$1.7KForm 4
DeMuth PeterChief Scientific OfficerDec 16, 2024OPTION EX.381$4.41$1.7KForm 4
Venkatesan JaydirectorNov 26, 2024X50,000$0.01$500.00Form 4
Venkatesan JaydirectorNov 26, 2024DISPOSED50,000$0.01$500.00Form 4
WILSON KAREN JdirectorNov 21, 2024AWARD4,100$5.12$21.0KForm 4
ADAMS JULIANdirectorNov 21, 2024AWARD4,100$5.12$21.0KForm 4
Ashe Carol GaildirectorNov 21, 2024AWARD4,100$5.12$21.0KForm 4
Venkatesan JaydirectorNov 21, 2024AWARD4,100$5.12$21.0KForm 4
RUFFOLO ROBERT RdirectorNov 21, 2024AWARD4,100$5.12$21.0KForm 4
Chudnovsky Yekaterinadirector, 10 percent owner: Nov 21, 2024AWARD4,100$5.12$21.0KForm 4
Nissenson AllendirectorNov 21, 2024AWARD4,100$5.12$21.0KForm 4
Connelly Robertdirector, officer: CEO, President and DirectorSep 30, 2024AWARD91,600$5.03$460.7KForm 4
DeMuth PeterChief Scientific OfficerSep 30, 2024AWARD29,800$5.03$149.9KForm 4
Haqq ChristopherSee RemarksSep 30, 2024AWARD28,200$5.03$141.8KForm 4
Chudnovsky Yekaterinadirector, 10 percent owner: Aug 12, 2024BUY3,442,341$5.81$20.0MForm 4
Venkatesan JaydirectorJun 28, 2024BUY50,000$5.00$250.0KForm 4
Venkatesan JaydirectorJun 28, 2024BUY50,000$0.01$500.00Form 4
Chudnovsky Yekaterinadirector, 10 percent owner: Jun 28, 2024BUY1,600,000$5.00$8.0MForm 4
Chudnovsky Yekaterinadirector, 10 percent owner: Jun 28, 2024BUY1,600,000$0.01$16.0KForm 4
Chudnovsky Yekaterinadirector, 10 percent owner: Mar 19, 2024BUY1,032,702$0.01$10.3KForm 4
Piekos BrianChief Financial OfficerFeb 1, 2024AWARD43,225$4.50$194.5KForm 4
Connelly Robertdirector, officer: CEO, President and DirectorFeb 1, 2024AWARD225,137$4.50$1.0MForm 4
Haqq ChristopherSee RemarksFeb 1, 2024AWARD28,200$4.50$126.9KForm 4
DeMuth PeterChief Scientific OfficerFeb 1, 2024AWARD29,800$4.50$134.1KForm 4
DeMuth PeterChief Scientific OfficerFeb 1, 2024AWARD342$4.50$1.5KForm 4